Lupin gets USFDA nod to market drug used to treat chronic hepatitis B
The company has received tentative approval from the United States Food and Drug Administration (FDA) for its abbreviated new drug application for Tenofovir Alafenamide tablets (25 mg), Lupin said in a statement. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - April 18, 2022 Category: Pharmaceuticals Source Type: news

Tenofovir vs. Entecavir Therapy in HBV: Long-term Renal Safety Tenofovir vs. Entecavir Therapy in HBV: Long-term Renal Safety
Do tenofovir and entecavir differ in their long-term impact on renal function in patients with hepatitis B?Journal of Viral Hepatitis (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - April 11, 2022 Category: Consumer Health News Tags: Gastroenterology Journal Article Source Type: news

PrEP Kidney Function Monitoring to Be Fine-Tuned PrEP Kidney Function Monitoring to Be Fine-Tuned
The risk of kidney-related adverse events among patients receiving tenofovir disoproxil fumarate-based oral HIV pre-exposure prophylaxis is small, a systematic review and meta-analysis revealed.Reuters Health Information (Source: Medscape Hiv-Aids Headlines)
Source: Medscape Hiv-Aids Headlines - March 18, 2022 Category: Infectious Diseases Tags: Nephrology News Source Type: news

Truvada (Emtricitabine Tenofovir DF) - updated on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - March 16, 2022 Category: Drugs & Pharmacology Source Type: news

Rwanda: Rwanda Acquires HIV Drugs Worth U.S.$7.6 Million
[New Times] The Ministry of Health of Health on Wednesday January 19 acquired 349,393 bottles of Tenofovir/Lamivudine/Dolutegravir (TLD - B/90) tablets, to be distributed to all Rwandans living with HIV/AIDS. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - January 19, 2022 Category: African Health Source Type: news

Safety of Tenofovir in Pregnant Women With COVID-19 Safety of Tenofovir in Pregnant Women With COVID-19
The antiviral tenofovir has emerged as a promising therapy for SARS-CoV-2 infection. Is it safe to use in pregnant women?American Journal of Epidemiology (Source: Medscape Hiv-Aids Headlines)
Source: Medscape Hiv-Aids Headlines - December 10, 2021 Category: Infectious Diseases Tags: Infectious Diseases Journal Article Source Type: news

SYMFI (efavirenz, lamivudine and tenofovir disoproxil fumarate) - updated on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - November 2, 2021 Category: Drugs & Pharmacology Source Type: news

Cabotegravir Bests TDF-FTC for HIV Prevention in Those at Risk
THURSDAY, Aug. 12, 2021 -- For men who have sex with men (MSM) and transgender women, long-acting injectable cabotegravir (CAB-LA, an integrase strand-transfer inhibitor [INSTI]) is superior to tenofovir disoproxil fumarate-emtricitabine (TDF-FTC)... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - August 12, 2021 Category: Pharmaceuticals Source Type: news

Dolutegravir Confirmed as Effective Second-Line HIV Therapy Dolutegravir Confirmed as Effective Second-Line HIV Therapy
A new randomized trial bolsters efficacy evidence for dolutegravir and finds no benefit in switching from tenofovir in second-line HIV treatment.Medscape Medical News (Source: Medscape Hiv-Aids Headlines)
Source: Medscape Hiv-Aids Headlines - July 22, 2021 Category: Infectious Diseases Tags: HIV/AIDS News Source Type: news

Symfi Lo (Efavirenz, Lamivudine and Tenofovir Disoproxil Fumarate Tablets) - updated on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - July 19, 2021 Category: Drugs & Pharmacology Source Type: news

Both HIV and Tenofovir Tied to Skeletal Deficits in Young People Both HIV and Tenofovir Tied to Skeletal Deficits in Young People
HIV is associated with ' substantial ' skeletal deficits toward the end of puberty, especially among girls, as is the antiretroviral tenovir disoproxil fumarate, a cross-sectional study shows.Reuters Health Information (Source: Medscape Hiv-Aids Headlines)
Source: Medscape Hiv-Aids Headlines - July 7, 2021 Category: Infectious Diseases Tags: HIV/AIDS News Source Type: news

Effectiveness and Renal Safety of TAF in Chronic HBV Effectiveness and Renal Safety of TAF in Chronic HBV
How does the renal safety of tenofovir alafenamide fumarate compare to that of tenofovir disoproxil fumarate in a real-world clinical setting? Can switching from TDF to TAF reverse renal impairment?Journal of Viral Hepatitis (Source: Medscape Critical Care Headlines)
Source: Medscape Critical Care Headlines - July 6, 2021 Category: Intensive Care Tags: Gastroenterology Journal Article Source Type: news

Outcomes Associated With Change From TDF to TAF in HIV-1 Outcomes Associated With Change From TDF to TAF in HIV-1
A new study looks at the effects of a treatment switch from tenofovir disoproxil fumarate to tenofovir alafenamide-containing ART regimens among HIV-1-infected patientsHIV Medicine (Source: Medscape Hiv-Aids Headlines)
Source: Medscape Hiv-Aids Headlines - July 1, 2021 Category: Infectious Diseases Tags: HIV/AIDS Journal Article Source Type: news

Temixys (lamivudine and tenofovir disoproxil fumarate)
Title: Temixys (lamivudine and tenofovir disoproxil fumarate)Category: MedicationsCreated: 6/16/2021 12:00:00 AMLast Editorial Review: 6/16/2021 12:00:00 AM (Source: MedicineNet HIV General)
Source: MedicineNet HIV General - June 16, 2021 Category: Infectious Diseases Source Type: news

HIV has detrimental effect on children ’ s growth and bone strength, finds landmark study
Children growing up with HIV infection have concerning deficits in skeletal strength which become more apparent towards the end of pubertal growth, finds the largest study to date to investigate the link between HIV and skeletal health in children. The study, conducted in Zimbabwe and published in The Lancet Child and Adolescent Health, identifies a link between these skeletal deficits and the first-line antiretroviral-HIV drug, tenofovir disproxil fumarate (TDF), which is widely used across sub-Saharan Africa. (Source: University of Bristol news)
Source: University of Bristol news - June 14, 2021 Category: Universities & Medical Training Tags: Research, International, Health; Faculty of Health Sciences, Faculty of Health Sciences, Bristol Medical School; Press Release Source Type: news